Skip navigation

Scottish business award for spectroscopy

9 January 2008

D3 Technologies Limited (now Renishaw Diagnostics Ltd.), a leader in Surface Enhanced Raman Spectroscopy (SERS), and a subsidiary of world-leading metrology and spectroscopy company Renishaw plc, was honoured with a spin-out recognition award at the recent University of Strathclyde Enterprise Awards. The award recognised D3 for its work on trace detection used in drug development, forensic science and medical diagnostics.

A successful spin-out from the University of Strathclyde, D3 Technologies attracted the interest of Renishaw plc, which acquired a 75% interest in the newly formed company in July 2007. Part of the investment was then used by D3 to purchase the business and assets of the analytical business unit (ABU) operated by Mesophotonics Limited, a spin-out company from the University of Southampton. The ABU develops and manufactures substrates used in SERS applications.

The Strathclyde Enterprise Awards aim to give recognition to some of Scotland's smartest and most inventive businesses which have been supported by the University's enterprise network. At the awards ceremony hosted by stv presenter Debi Edward, nine awards were granted for projects as diverse as drug development, website creation, environmentally-sound kettles and coffee cups with adaptable handles.

Speaking about his company's award, Professor Ewen Smith, D3's CEO, said, "We are delighted to receive this award which recognises the work of all our team in developing improved DNA-based diagnostic tests to detect diseases, or the genetic predisposition to diseases. I would also like to thank the University of Strathclyde and Renishaw for their support and belief in the work of D3."

Dr David McBeth, Director of Research and Innovation at Strathclyde, said: "The awards have been presented to give credit to the innovative, creative companies the University has advised and supported and to inspire others to follow their example."

 

Enquiries: Caterina Netti, Head of Operations and Technology (+44 141 5577900)

About Renishaw Diagnostics Ltd

Renishaw Diagnostics Ltd, formerly D3 Technologies Ltd, was a Strathclyde University spin-out before being acquired by the Renishaw Group, which is a leading global supplier of engineering technologies, medical devices and Raman spectroscopy systems. It is focused on developing and commercialising its first in vitro diagnostic (IVD) and clinical research products, with the goal of establishing Renishaw Diagnostics as the premium provider of automated, multiplex, high sensitivity molecular diagnostics products for the detection of human infectious diseases.